Clinical Trials Logo

Cesarean Section clinical trials

View clinical trials related to Cesarean Section.

Filter by:

NCT ID: NCT03842527 Completed - Cesarean Section Clinical Trials

Gastric Voume Assessment for Aspiration Risk in OB ERAS Patients

Start date: February 11, 2019
Phase: N/A
Study type: Interventional

In recent years, human and animal studies have found that carbohydrate-loading prior to surgery leads to improved response to surgical stress and improved postoperative well-being when compared to traditional fasting guidelines. Such positive findings have lead to the increased use of preoperative intake of carbohydrate rich drinks prior to elective surgeries. However, one of the biggest risks during surgery when a patient is asleep is having stomach contents come up into the lungs. For this reason, a stomach that is empty or has minimal amount of contents is safest. Historically, patients have been instructed not to eat or drink for 8 hours before surgery because it was thought to lower the risk of having fluid or contents in the stomach. This is the current practice patients are asked to follow before undergoing a C-section. However, non-pregnant patients undergoing other surgeries are instructed to have carbohydrate-rich drinks because of the potential benefits. Using ultrasound, the abdomen can be simply scanned to see if there are stomach contents present before surgery. This can allow for the potential determination of what the aspiration risk may be. What the investigators want to do is look at the safety of using carbohydrate-loading in patients having a C-section. The investigators want to make sure that patients who follow carbohydrate-loading by having a clear, sugary drink 3 hours before a C-section are not at greater risk of having a large amount of stomach contents and be at higher risk of aspirating. This will be done by taking an ultrasound scan of the stomach that will tell the investigators if there are contents in the stomach and whether there is a risk of aspiration. Patients having an elective C-section will be randomized into two groups. The first group will follow carbohydrate-loading by having a drink of apple juice or cranberry juice cocktail the night before (800mL) and 3 hours before (400mL) the C-section. The second group will follow standard practice of not eating or drinking less than 8 hours prior to surgery. An anesthesiologist will ultrasound the stomach 1 hour before the scheduled procedure time. The first ultrasound will be completed in the supine position (lying on back). The second will be done in the right lateral decubitus position (lying on right side). This should not take more than 5-10 minutes total.

NCT ID: NCT03834454 Completed - Clinical trials for Postoperative Complications

Bupivacaine 5 mg vs 7.5 mg for Spinal Anesthesia in Cesarean Delivery in Indonesian Population

Start date: October 1, 2013
Phase: N/A
Study type: Interventional

This study aims to evaluate the efficacy of hyperbaric 5 mg bupivacaine + fentanyl 25 mcg versus hyperbaric 7.5 mg bupivacaine + fentanyl 25 mcg to lower incidence of hypotension

NCT ID: NCT03805945 Completed - Cesarean Section Clinical Trials

Effect of Dexmedetomidine on Parturient Undergoing Elective Cesarean Section.

Start date: June 1, 2019
Phase: Phase 4
Study type: Interventional

The purpose of this study was to investigate whether dexmedetomidine used in the perioperative period of elective cesarean section can improve maternal mood, improve analgesic effect, improve maternal recovery quality, and then make the breastfeeding better.At the same time, this experiment attempts to explore the optimal dose of dexmedetomidine to produce the above effect.

NCT ID: NCT03792191 Completed - Cesarean Section Clinical Trials

Ultrasonography Versus Palpation for Spinal Anesthesia in Obese Parturients Undergoing Cesarean Delivery

Start date: January 16, 2019
Phase: N/A
Study type: Interventional

The study will compare between preprocedural ultrasonography and the conventional palpation technique for spinal anesthesia in obese parturients undergoing elective cesarean delivery

NCT ID: NCT03775655 Completed - Cesarean Section Clinical Trials

Low Dose Hyperbaric Bupivacaine and Dexmedetomidine as an Adjuvant, Caesarean Section

Start date: September 1, 2018
Phase: Phase 2/Phase 3
Study type: Interventional

The aim of this study is to evaluate the effectiveness of low dose scheme with dexmedetomidine as an adjuvant. Taking in consideration optimum intraoperative surgical conditions, best post-operative pain free experience, and more stable hemodynamic.

NCT ID: NCT03772886 Terminated - Obesity Clinical Trials

Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball

Start date: September 9, 2019
Phase: N/A
Study type: Interventional

This study aims to determine if using the peanut ball during labor reduces the cesarean delivery rate when compared to normal intrapartum management (no peanut ball) in the obese patient population.

NCT ID: NCT03767920 Completed - Cesarean Section Clinical Trials

Role of Dexamethasone in Transversus Abdominis Plane Block After Cesarean Section

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Our aim to study the efficacy of bupivacaine 0.25% with dexamethasone and that of bupivacaine 0.25% alone in transversus abdominis plane (TAP) block for postoperative analgesia in patients undergoing an elective Caesarean section. - Group 1: bupivacaine 0.25% + dexamethasone 8 mg - Group 2: bupivacaine 0.25% A prospective Randomized Interventional double-blind study.

NCT ID: NCT03764202 Completed - Cesarean Section Clinical Trials

Determination of Sufentanil in Breast Milk of Puerpera

Start date: August 2015
Phase: Phase 4
Study type: Interventional

To determination of sufentanil in human breast milk during the administration of the sufentanil via the analgesic infusion pump and after the administration, to determine whether the breastfeeding after clinical anesthetic or analgesic administration has an effect on the infant and provide a reference for the security issues.

NCT ID: NCT03760718 Active, not recruiting - Cesarean Section Clinical Trials

Chloroprocaine Lavage to Improve Outcomes Related to Operative Cesarean Delivery

CLOR-PRO
Start date: September 30, 2019
Phase: Early Phase 1
Study type: Interventional

The long term objective is to show that intraperitoneal chloroprocaine can be used an alternative option to avoid general anesthesia during cesarean delivery, to alleviate mother's discomfort from surgical pain, reduce complications, and improve the birth experience. The objectives in this study are to determine the amount of chloroprocaine that is absorbed into the blood in order to create a plasma concentration time profile and to determine the incidence of side effects to help guide selection of an appropriate concentration for future study.

NCT ID: NCT03741907 Completed - Cesarean Section Clinical Trials

Comparing French Ambulatory and MISGAV-LADACH C-Section Techniques

MLC
Start date: August 27, 2018
Phase: N/A
Study type: Interventional

In the last decades cesarean section rates are getting higher in many countries. The rise in those rates encourages obstetricians to improve operative techniques for a better maternal and fetal outcome. Despite its worldwide spread, a general consensus on the most appropriate technique to use has not yet been reached. The most known surgical technique is the MLC . A modified extraperitoneal method of caesarean section :" French Ambulatory Cesarean Section ( FAUCS) was described in the middle of the 90's by "Denis Fauck" and "Jacques Henri Ravina " However, no study comparing these two cesarean techniques was conducted. From where the investigators initiate this study .